Home

OrbiMed Israel GP II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/04/17

Trade details

Type
Insider sale
Amount
$52,284.6
Shares · price
28,110 sh · $1.86 a share
Held after
2,426,665 sh
Trade date
23/04/14
Filed
23/04/17
Days to filing
3 days

Sold 1.1% of holdings

Share of holding sold
1.1%

Damora Therapeutics trades, last 26 weeks

What else happened in Damora Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/15~23/05/14

OrbiMed Israel GP II's recent trades

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $10M

    Filed 09/30

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $5.1M

    Filed 09/30

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $1M

    Filed 09/30

  • OrbiMed Israel GP II

    SellAdicet Bio

    $263.5K

    Filed 04/09

  • OrbiMed Israel GP II

    SellAdicet Bio

    $204.6K

    Filed 04/09